The diagnosis of prostate cancer is complex, as PSA can be elevated in benign conditions, such as prostatitis, or benign prostatic hyperplasia (BPH), where there is a risk of false positive interpretation, while some aggressive tumors may present with PSA levels within the normal range, and thus being under-diagnosed (4). The gene discussed is KLK3; the disease is urogenital neoplasm.